Market Tracker

06/28 12:59pm ET

Oramed Pharmaceuticals Inc (NASDAQ:ORMP)

8.14
Delayed Data
As of 12:37pm ET
 +0.17 / +2.13%
Today’s Change
4.15
Today|||52-Week Range
10.74
-4.80%
Year-to-Date
No recent news for Oramed Pharmaceuticals Inc.

Today’s Trading

Previous close7.97
Today’s open8.25
Day’s range8.10 - 8.50
Volume11,411
Average volume (3 months)126,144
Market cap$104.5M
Dividend yield--
Data as of 12:37pm ET, 06/28/2016

Growth & Valuation

Earnings growth (last year)-8.06%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book3.71

Competitors

 Today’s
change
Today’s
% change
AQXPAquinox Pharmaceutic...+0.20+3.25%
DPRXDipexium Pharmaceuti...+0.04+0.40%
--EcoGreen Internation...+0.00+1.94%
PRQRProQR Therapeutics N...+0.07+1.51%
Data as of 12:42pm ET, 06/28/2016

Financials

Next reporting dateJune 29, 2016
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$0.00
Annual profit (last year)-$7.2M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Nadav Kidron
Chief Operating Officer &
VP-Business Development
Joshua Hexter
Corporate headquarters
Jerusalem, Jerusalem

Forecasts